News

The MGH Cancer Center presented its annual MGH Award in Cancer Research on April 8 to Michael R. Stratton, MD, PhD, director of the Wellcome Trust Sanger Institute.

MGH Cancer Center awards research prize

20/May/2011

GH RESARCH AWARD: Daniel Haber, MD, PhD, director of the MGH Cancer Center, left, and Stratton

 

The MGH Cancer Center presented its annual MGH Award in Cancer Research on April 8 to Michael R. Stratton, MD, PhD, director of the Wellcome Trust Sanger Institute. Stratton’s laboratory mapped and identified the high-risk breast cancer susceptibility gene, BRCA2, and subsequently defined several moderate-risk breast cancer susceptibility genes. Under his leadership, the Sanger Cancer Genome Project identified the mutation of B-RAF as a common driver oncogene in melanoma and has characterized the genomic mutational landscape in multiple cancers.

 

patient

U.S. News and World Report Best Hospitals 2014-2015

U.S. News & World Report ranks Mass General #1 in New England and #2 in the nation based on our quality of care, patient safety and reputation in 16 clinical specialties.

Search the Mass General news archive

Search the archive for previously published news articles, press releases and publications.

View all departments

Departments and Centers at Mass General have a reputation for excellence in patient care. View a list of all departments.